FOLH1 and glioblastoma: Gupta et al. (2020b) also published a report of increased 68Ga-PSMA-11 (HBED-CC) uptake on PET imaging of a posttreatment GBM with suspected recurrence, which was ultimately diagnosed as pseudoprogression based on subsequent imaging.